Distribution, Severity and Mortality of COVID-19 in Relation to Blood Group and Rh Factor
DOI:
https://doi.org/10.3889/oamjms.2026.12134Keywords:
COVID-19, ABO blood group system, RhAbstract
BACKGROUND: During the Covid-19 pandemic, a number of investigators reported that in patients with different blood groups the virus had a disparate influence regarding the severity and the outcome of the infection.
AIM: The goal of our study was to determine if there is an association between blood groups and Rh factor regarding the severity and mortality from COVID-19 in our analyzed patient population.
METHODS: We conducted a retrospective observational study of 250 patients with COVID-19 disease, treated as ambulatory or hospitalized patients in several health facilities during a time period of one year, from November 2020 till November 2021.
RESULTS: The majority of patients in our cohort were confirmed to have blood group A - 115 (46%), followed by blood group O - 67 (26.8%) patients, 45 (18%) patients were with blood group B, and 23 (9.2%) patients were with blood group AB. The data generated from our analysis revealed a higher than standard prevalence of SARS-CoV-2 infections among individuals with blood group A. Also, the analysis shows that patients with blood group A experience a more severe clinical course of the disease, as well as higher mortality, compared to patients with other blood groups. There is a substantial difference between Rh positive and Rh negative patients in terms of the severity of the disease. Rh positive patients more frequently experience a severe clinical course, confirmed by statistical significance, but the Rh factor does not affect the outcome of the infection.
CONCLUSIONS: The results from our analysis showed that patients with blood group A manifest a more severe clinical course of the disease and a higher mortality rate compared to patients with other blood groups, but statistical significance between them could not be documented.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Saad IM, Ghorab OK, Al-Salmi S et al. COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 202 May 18;20 (01):35. https://doi.org/10.1186/s12941-021-00438-7 PMid:34006330 PMCid:PMC10079051
Loganathan S , Kuppusamy M, Wankhar W et al. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gateway to multiple organ failure syndromes. Respir Physiol Neurobiol. 2021 Jan;283:103548. https://doi.org/10.1016/j.resp.2020.103548 PMid:32956843 PMCid:PMC7500408
Kinane DF, Blackwell CC, Brettle RP et al. ABO blood group, secretaor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clinc Res Ed).1982 jul 3;285(6334): 7-9. https://doi.org/10.1136/bmj.285.6334.7 PMid:6805820 PMCid:PMC1499148
Foster MT, Labrum AH. Relation of infection with Neisseria gonorrhoeae to ABO blood groups. J Infect Dis. 1976 Mar;133(3):329-330. https://doi.org/10.1093/infdis/133.3.329 PMid:1254989
Borén T, Falk P, Roth KA et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993 Dec 17;262(5141):1892-5. https://doi.org/10.1126/science.8018146 PMid:8018146
Wang DS, Chen DL, Ren C et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer.2012 Jul 15;131(2):461-8. https://doi.org/10.1002/ijc.26376 PMid:21858814
Chen Z, Yang SH, Xu H, Li JJ. ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Sci. Rep.2016 Mar 18;6: 23250. https://doi.org/10.1038/srep23250 PMid:26988722 PMCid:PMC4796869
Wolpin BM, Kraft P, Gross M et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010 Feb 1;70, 1015-1023. https://doi.org/10.1158/0008-5472.CAN-09-2993 PMid:20103627 PMCid:PMC2943735
Silva-Filho JC, Farias de Melo CG and de Oliveira JL. The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions. Med Hypotheses 2020 Nov; 144:110155. https://doi.org/10.1016/j.mehy.2020.110155 PMid:33254482 PMCid:PMC7395945
Severe Covid GWAS Group, Ellinghaus D, Degenhardt F, Bujanda L et al. Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med. 2020; 383:1522-1534. https://doi.org/10.1056/NEJMoa2020283
PMid:32558485 PMCid:PMC7315890
Pendu, JL, Breiman A, Rocher J, Dion M, Ruvoën-Clouet N. ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data. Viruses 2021; 13: 160. https://doi.org/10.3390/v13020160 PMid:33499228 PMCid:PMC7911989
Goel R, Bloch EM, Pirenne F et al., the ISBT COVID-19 Working Group. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group. Vox Sanguinis 2021; 116(8): 849-861. https://doi.org/10.1111/vox.13076 PMid:33578447 PMCid:PMC8014128
Boudin L, Janvier F, Bylicki O. Dutasta F. ABO Blood Groups Are Not Associated with Risk of Acquiring the SARS-CoV-2 Infection in Young Adults. Haematologica 2020 Dec1;105 (12):2841-2843. https://doi.org/10.3324/haematol.2020.265066 PMid:33256383 PMCid:PMC7716357
Zhao J, Yang Y, Huang H et al. Relationship between the ABO blood group and the COVID-19 susceptibility. Clin Infect Dis. 2021;73:328-331. https://doi.org/10.1093/cid/ciaa1150 PMid:32750119 PMCid:PMC7454371
Pourali F, Afshari M, Alizadeh-Navaei Ret al. Relationship between Blood Group and Risk of Infection and Death in COVID-19: A Live Meta-Analysis. New Microbes New Infect. 2020 Sep;37:100743. https://doi.org/10.1016/j.nmni.2020.100743 PMid:32837730
Bojadzieva TM, Velkova E, Ilijevska VD, Petrovi E. Osnovi na labaratoriskata transfuziona medicina, 2021.
Kim Y, Latz C, DeCarlo C, Lee S et al. Relationship between blood type and outcomes following COVID-19 infection. Semin Vasc Surg.2021 Sep;34(3)125-131. https://doi.org/10.1053/j.semvascsurg.2021.05.005 PMid:34642032 PMCid:PMC8286549
Soares DMB, Araújo DABS, de Souza JLB et al. Correlation between ABO blood type, susceptibility to SARS-CoV-2 infection and COVID-19 disease severity: A systematic review. Hematol Transfus Cell Ther. 2022 Nov 30. https://doi.org/10.1016/j.htct.2022.11.001 PMid:36467112
Cheng Y, Cheng G, Chui CH et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA. 2005; 293:1450-1451. https://doi.org/10.1001/jama.293.12.1450-c
Guillon P, Clement M, Sebille V et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008 Dec;18 (12):1085-1093. https://doi.org/10.1093/glycob/cwn093 PMid:18818423 PMCid:PMC7108609
Matzhold EM, Berghold A, Bemelmans MKB et al. ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2. Transfusion. 2021 Sep; 61(9):2736-2745. https://doi.org/10.1111/trf.16567 PMid:34151460 PMCid:PMC8447157
Solmaz İ, Araç S. ABO blood groups in COVID-19 patients; cross-sectional study. Int. J. Clin. Pract. 2021 Apr;75(4):e13927. https://doi.org/10.1111/ijcp.13927 PMCid:PMC7883261
Aktimur SH, Ahmet S, Yazicioglu B, Gunes AK, Serhat G. The assessment of the relationship between ABO blood groups and Covid-19 infection. Int J Hematol Oncol. 2020;31(3):121-125 https://doi.org/10.4999/uhod.204348
Stowell SR, Stowell CP. Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism. Vox Sang. 2019;114:535-552. https://doi.org/10.1111/vox.12786 PMid:31090093
Ladikou EE, Sivaloganathan H, Milne KM et al. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clin Med. 2020 Sep;20(5):e178-e182. https://doi.org/10.7861/clinmed.2020-0346 PMid:32694169 PMCid:PMC7539718
Velasco A, Peñarrubia-Ponce MJ, Álvarez FJ, Fuente I, Pérez-González S, and Andaluz-Ojeda D. ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points. Front Med (Lausanne). 2022;9: 882477. https://doi.org/10.3389/fmed.2022.882477 PMid:35547235 PMCid:PMC9081929
Latz CA, DeCarlo C, Boitano L et al. Blood type and outcomes in patients with COVID-19. Ann. Hematol. 2020 Sep;99(9):2113-2118. https://doi.org/10.1007/s00277-020-04169-1 PMid:32656591 PMCid:PMC7354354
Gamboa-Aguilar J, Zamorano-Montaño ÁC, Enriquez-Osorio A et al. ABO blood group, atherothrombotic comorbidities, and COVID-19: a case-control study of their association in the Mexican population. Arch. Med. Res. 2022 Jan;53(1):100-108. https://doi.org/10.1016/j.arcmed.2021.09.005 PMid:34649737 PMCid:PMC8504860
Badedi M, Alnami A, Darraj H et al. Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia. Medicine. 2021 July;100(30). https://doi.org/10.1097/MD.0000000000026738 PMid:34397712 PMCid:PMC8322480
Wu S-C, Arthur CM, Jan H-M et al. Blood group A enhances SARS-CoV-2 infection. Blood. 2023 Aug 24; 142(8): 742-747. https://doi.org/10.1182/blood.2022018903 PMid:37367252 PMCid:PMC10294591
JG , Schull MJ , Vermeulen MJ , Park AL. Association between ABO and Rh blood groups and SARS-CoV-2 infection or severe COVID-19 illness: a population-based cohort study. Ann Intern Med. 2020 Nov 24: M20-451. https://doi.org/10.7326/M20-4511 PMid:33226859 PMCid:PMC7711653
Zietz M, Zucker J, Tatonetti NP. Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun. 2020 Nov 13;11(1):5761. https://doi.org/10.1038/s41467-020-19623-x PMid:33188185 PMCid:PMC7666188
Abdollahi A, Mahmoudi-Aliabadi M, Mehrtash V, Jafarzadeh B, Salehi M. The novel coronavirus SARS-CoV-2 vulnerability association with ABO/Rh blood types. Iran J Pathol. 2020;15 (3):156-160. https://doi.org/10.30699/ijp.2020.125135.2367 PMid:32754209 PMCid:PMC7354076
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Gazmend Amzai, Milena Srbinoska-Bogatinoska, Oliver Karanfilski, Glorija Stefanoska-Tosheska, Tatjana Kjosevska, Eleonora Grozdanova, Argjent Muca, Tatjana Proseva, Lidija Poposka, Marija Dimzova (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
